Terms: = Germ cell tumor AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207
5143 results:
1. LncRNA NDUFA6-DT: A Comprehensive Analysis of a Potential LncRNA Biomarker and Its Regulatory Mechanisms in Gliomas.
Huang R; Kong Y; Luo Z; Li Q
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674418
[TBL] [Abstract] [Full Text] [Related]
2. Role of Protein Tyrosine Phosphatase Receptor Type E (PTPRE) in Chemoresistant Retinoblastoma.
Mohren L; Doege A; Miroschnikov N; Dräger O; Busch MA; Dünker N
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674157
[TBL] [Abstract] [Full Text] [Related]
3. Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs.
Kraft T; Grützmann K; Meinhardt M; Meier F; Westphal D; Seifert M
Acta Neuropathol Commun; 2024 Apr; 12(1):67. PubMed ID: 38671536
[TBL] [Abstract] [Full Text] [Related]
4. Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
[TBL] [Abstract] [Full Text] [Related]
5. Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment.
Zhang Y; Zheng J; Chen M; Zhao S; Ma R; Chen W; Liu J
BMC Cancer; 2024 Apr; 24(1):519. PubMed ID: 38654216
[TBL] [Abstract] [Full Text] [Related]
6. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
[TBL] [Abstract] [Full Text] [Related]
7. Transient receptor potential vanilloid-1 (TRPV1) channels act as suppressors of the growth of glioma.
Cheng J; Zeng M; Peng B; Li P; Zhao S
Brain Res Bull; 2024 Jun; 211():110950. PubMed ID: 38631651
[TBL] [Abstract] [Full Text] [Related]
8. Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through Stat3/akt signaling pathway.
Yao N; Ma Q; Yi W; Zhu Y; Liu Y; Gao X; Zhang Q; Luo W
J Cancer Res Clin Oncol; 2024 Apr; 150(4):202. PubMed ID: 38630320
[TBL] [Abstract] [Full Text] [Related]
9. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
[TBL] [Abstract] [Full Text] [Related]
10. Combined therapy of dabrafenib and an anti-HER2 antibody-drug conjugate for advanced BRAF-mutant melanoma.
Li W; Zheng C; Xu X; Xia Y; Zhang K; Huang A; Zhang X; Zheng Y; Chen G; Zhang S
Cell Mol Biol Lett; 2024 Apr; 29(1):50. PubMed ID: 38594618
[TBL] [Abstract] [Full Text] [Related]
11. Haploinsufficiency of phosphodiesterase 10A activates PI3K/akt signaling independent of PTEN to induce an aggressive glioma phenotype.
Nuechterlein N; Shelbourn A; Szulzewsky F; Arora S; Casad M; Pattwell S; Merino-Galan L; Sulman E; Arowa S; Alvinez N; Jung M; Brown D; Tang K; Jackson S; Stoica S; Chittaboina P; Banasavadi-Siddegowda YK; Wirsching HG; Stella N; Shapiro L; Paddison P; Patel AP; Gilbert MR; Abdullaev Z; Aldape K; Pratt D; Holland EC; Cimino PJ
Genes Dev; 2024 Apr; 38(5-6):273-288. PubMed ID: 38589034
[TBL] [Abstract] [Full Text] [Related]
12. IQGAP3 promotes the progression of glioma as an immune and prognostic marker.
Gao X; Ge J; Gao X; Mei NA; Su Y; Shan S; Qian W; Guan J; Zhang Z; Wang L
Oncol Res; 2024; 32(4):659-678. PubMed ID: 38560572
[No Abstract] [Full Text] [Related]
13. The interplay between autophagy and ferroptosis presents a novel conceptual therapeutic framework for neuroendocrine prostate cancer.
Wang Y; Wu N; Li J; Liang J; Zhou D; Cao Q; Li X; Jiang N
Pharmacol Res; 2024 May; 203():107162. PubMed ID: 38554788
[TBL] [Abstract] [Full Text] [Related]
14. LPCAT1 promotes melanoma cell proliferation via akt signaling.
Wang Y; Huang Y; Wang Y; Zhang W; Wang N; Bai R; Luo R; Tuo H; Zheng Y
Oncol Rep; 2024 May; 51(5):. PubMed ID: 38551165
[TBL] [Abstract] [Full Text] [Related]
15. WTAP regulates the production of reactive oxygen species, promotes malignant progression, and is closely related to the tumor microenvironment in glioblastoma.
Ji Q; Guo Y; Li Z; Zhang X
Aging (Albany NY); 2024 Mar; 16(6):5601-5617. PubMed ID: 38535989
[TBL] [Abstract] [Full Text] [Related]
16. Dual-specificity kinase DYRK3 phosphorylates p62 at the Thr-269 residue and promotes melanoma progression.
Lee YH; Yoon AR; Yun CO; Chung KC
J Biol Chem; 2024 Apr; 300(4):107206. PubMed ID: 38519031
[TBL] [Abstract] [Full Text] [Related]
17. Interleukin 3 Inhibits Glutamate-Cytotoxicity in Neuroblastoma cell Line.
Matus V; Castro-Guarda M; Cárcamo-Fierro J; Morera FJ; Zambrano A
Neurochem Res; 2024 May; 49(5):1373-1386. PubMed ID: 38512424
[TBL] [Abstract] [Full Text] [Related]
18. Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors.
Muraro E; Montico B; Lum B; Colizzi F; Giurato G; Salvati A; Guerrieri R; Rizzo A; Comaro E; Canzonieri V; Anichini A; Del Vecchio M; Mortarini R; Milione M; Weisz A; Pizzichetta MA; Simpson F; Dolcetti R; Fratta E; Sigalotti L
Front Immunol; 2024; 15():1336566. PubMed ID: 38510242
[TBL] [Abstract] [Full Text] [Related]
19. NPS-2143 inhibit glioma progression by suppressing autophagy through mediating akt-mTOR pathway.
Nie JL; Li Q; Yin HT; Yang JH; Li M; Li Q; Fan XH; Zhao QQ; Wen ZP
J Cell Mol Med; 2024 Apr; 28(7):e18221. PubMed ID: 38509759
[TBL] [Abstract] [Full Text] [Related]
20. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives.
Malekan M; Haass NK; Rokni GR; Gholizadeh N; Ebrahimzadeh MA; Kazeminejad A
Life Sci; 2024 May; 345():122563. PubMed ID: 38508233
[TBL] [Abstract] [Full Text] [Related]
[Next]